Join Jasmine in the fight for sight on Thursday 13 October in our third annual Hope in Sight Giving Day. Find out how you can triple your impact and raise vital funds for life-changing gene therapy research.
Join Professor Robyn Guymer, Associate Professor Lyndell Lim and Associate Professor Peter van Wijngaarden on World Sight Day, 13 October, to discuss the latest in vision research.
In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.
Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat blindness – but there’s a critical need for education programs to help them make informed choices about future treatments.
A registry gathering vital information on people with inherited retinal diseases will help drive research into the most common cause of legal blindness in working-age Australians.
Retinal gene therapy researchers Dr Tom Edwards and Dr Sloan Wang are developing a potential gene therapy to ‘melt’ the crystals on the retina which impair vision in people with Bietti’s Crystalline Dystrophy.
